Latest TAP Pharmaceuticals Stories
ABBOTT PARK, Ill., Aug. 16, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S.
ABBOTT PARK, Ill., June 20, 2011 /PRNewswire/ -- Abbott announced today that the U.S.
ABBOTT PARK, Ill., March 11 /PRNewswire-FirstCall/ -- The U.S.
BETHESDA, Md., Dec. 4 /PRNewswire/ -- Drs. Neal Shore and E.
PITTSBURGH, Nov. 10 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S.
PARSIPPANY, N.J., Aug. 4 /PRNewswire/ -- Ferring Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved the trade name FIRMAGON(R) (degarelix for injection) for its prostate cancer treatment previously marketed under the generic name degarelix.
- This approval will provide greater convenience and broader access to an effective treatment option to the 50 million Americans(1) suffering from frequent heartburn - Once-daily, prescription-strength Prevacid(R) 24HR is the first OTC proton pump inhibitor approved for the treatment of frequent heartburn in the US since 2003 - Prescription-strength Prevacid 24HR treats frequent heartburn for a full 24 hours BASEL, Switzerland, May 14 /PRNewswire/ -- Novartis announced today that...
- A poem in which the author retracts something said in an earlier poem.